The CEO of a California biotechnology company was sentenced today to seven years in prison for a securities fraud scheme that resulted in approximately $28 million in investor losses and obstruction of a related U.S. Securities and Exchange Commission (SEC) investigation. Read More
Home » Biotech CEO Sentenced for $28M COVID-19 Securities Fraud Scheme and Obstruction of Related Investigation
Biotech CEO Sentenced for $28M COVID-19 Securities Fraud Scheme and Obstruction of Related Investigation
Related Posts
Former Maury County, Tennessee, Corrections Officer Sentenced for
A former corrections officer of the Maury County, Tennessee, Jail was sentenced yesterday in federal court in Nashville, Tennessee, to 60 months in prison and… BronFormer Maury County, Tennessee, Corrections Officer Sentenced for
Sixteen Cardiology Practices to Pay a Total of $17.7M to Resolve False
Sixteen separate cardiology practices and associated physicians, located across 12 states, have agreed to pay amounts totaling $17,761,564 to resolve allegations that they each violated… BronSixteen Cardiology Practices to Pay a Total of $17.7M to Resolve False
United States Joins Lawsuit Against Former Executives of Kabbage Inc.
The United States has intervened and filed a complaint against Robert Frohwein, Kathryn Petralia and Spencer Robinson, three former executives of Kabbage Inc., a now-bankrupt… BronUnited States Joins Lawsuit Against Former Executives of Kabbage Inc.